Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2004
11/18/2004US20040229305 Novel polynucleotides encoding useful polypeptides in corynebacterium glutamicum SSP. lactofermentum
11/18/2004US20040229303 Novel thermostable proteolytic enzymes and uses thereof in peptide and protein synthesis
11/18/2004US20040229272 Beta 1,3-galactosyltransferases from C. jejuni
11/18/2004US20040229263 Comprises campylobacter glycosyltransferase for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders
11/18/2004US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004US20040229255 Using fermentive processing to preparing lysine in trehalose 6-phosphate synthase attenuated coryneform bacterium; for use in medicines, cosmetics and nutraceuticals
11/18/2004US20040229251 Using fluorescently labeled guanosine triphosphate to accurately determine activity of nucleotide cyclase/orphan receptor; enzyme inhibitors; high throughput assay; drug screening
11/18/2004US20040229250 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
11/18/2004US20040229242 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein
11/18/2004US20040229241 Comprises nucleotide sequences coding amine oxidase for use in identifying modulator for treatment of neoplastic cell proliferation and differentiation; antitumor/anticarcinogenic agents
11/18/2004US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004US20040229236 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB
11/18/2004US20040229233 Human housekeeping genes and human-tissue specific genes
11/18/2004US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004US20040229229 Use of multiple recombination sites with unique specificity in recombinational cloning
11/18/2004US20040228849 IKB kinase, subunits thereof, and methods of using same
11/18/2004US20040226672 using cutlinase, lipases in manufacturing paper
11/18/2004US20040226502 Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase
11/18/2004DE10320653A1 Verfahren zur Produktion von Lipase A process for the production of lipase
11/18/2004DE10047857B4 Verfahren zur selektiven biokatalytischen Modifizierung von Peptiden und Proteinen Biocatalytic process for the selective modification of peptides and proteins
11/18/2004CA2526341A1 Variant subtilisin enzymes (subtilases)
11/18/2004CA2525387A1 Glucose dehydrogenase and its preparation
11/18/2004CA2524680A1 Enrichment of enzymatic cleavage products
11/18/2004CA2523764A1 Isolated bacillus mhkcel cellulase
11/18/2004CA2523722A1 Novel bacillus bagcel cellulase
11/18/2004CA2523400A1 Variant lipolytic enzymes
11/18/2004CA2522574A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket
11/17/2004EP1477567A1 Method for recombinant production of mammalian proteins and proteins obtainable by such method
11/17/2004EP1477566A1 Germ extract for cell-free protein synthesis and process for producing the same
11/17/2004EP1477565A1 Method of producing L-lysine by fermentation
11/17/2004EP1477564A2 Human synthetases
11/17/2004EP1477563A2 Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use
11/17/2004EP1477562A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
11/17/2004EP1477558A1 Selection methods
11/17/2004EP1477557A1 transgenic plant resistant to mycotoxins and methods
11/17/2004EP1476840A2 Crystal structures of jnk-inhibitor complexes and binding pockets thereof
11/17/2004EP1476563A2 Method for the recombination of genetic elements
11/17/2004EP1476562A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
11/17/2004EP1476559A2 Process for producing levodione
11/17/2004EP1476555A2 YkuR POLYNUCLEOTIDES AND POLYPEPTIDES
11/17/2004EP1476547A2 Targeted chromosomal mutagenesis using zinc finger nucleases
11/17/2004EP1476546A2 Functionalization of carotenoid compounds
11/17/2004EP1476545A2 Aggrecanase molecules
11/17/2004EP1476544A1 Enone reductase
11/17/2004EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11/17/2004EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004EP1476464A1 Variants of the alpha 1 subunit of human ampk
11/17/2004EP1476462A2 Novel fungal lipase
11/17/2004EP1476153A2 Method of treating and preventing bone loss
11/17/2004EP1476128A2 Lipase inhibiting composition
11/17/2004EP1476012A1 Transgenic animals expressing prkag3
11/17/2004EP1427439A4 Gamma three protease
11/17/2004EP1274847B1 Sham-sensitive terminal oxidase gene from xylose-fermenting yeast
11/17/2004EP1252292A4 Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
11/17/2004EP1223799A4 Non-transgenic herbicide resistant plants
11/17/2004EP1196606B1 Lytic enzyme
11/17/2004EP1115856B1 Method for making insertional mutations
11/17/2004EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004EP1040193B1 Promoter from ashbya gossypii
11/17/2004EP0939798B1 Antifungal proteins, dna coding therefore, and hosts incorporating same
11/17/2004EP0888455B1 Alkaline cellulase and method of producing same
11/17/2004EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
11/17/2004CN1547613A Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is
11/17/2004CN1547609A Improved process for converting nitriles to carboxylic acids using nitrilase
11/17/2004CN1547608A Modified factor IX
11/17/2004CN1546667A D-lactate dehydrogenase gene, recombinant vector containing the gene and host cell
11/17/2004CN1546659A Lamb ferment rennet ultrasonic extraction method
11/17/2004CN1176211C Ribonuclease extracting process
11/16/2004US6818806 Maize lls1 promoter
11/16/2004US6818805 Phosphatase stress-related proteins and methods of use in plants
11/16/2004US6818803 For renewable production of fuel/chemical feedstocks; glucanases
11/16/2004US6818755 Nucleic acid molecules encoding 10-deacetylbaccatin III-O-acetyl transferase and related products
11/16/2004US6818754 For therapy/diagnosis/research; forensics/genetic mapping/mutation detection
11/16/2004US6818751 Antigen presenting cell expressing prostate-specific protein; for prevention/monitoring
11/16/2004US6818447 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
11/16/2004US6818444 Nucleotide sequences coding preferential polypeptide for use in treatment of immune defects in animals; for use in veterinary medicine
11/16/2004US6818443 Fluorescent proteins
11/16/2004US6818440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and alzheimer's
11/16/2004US6818439 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
11/16/2004US6818433 Nematode PGM-like sequences
11/16/2004US6818432 Nucleotide sequences encoding the ptsH gene
11/16/2004US6818431 Resistant to heat inactivation/improved incorporation; for automated terminator dna sequencing
11/16/2004US6818429 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
11/16/2004US6818428 For diagnosing spondyloepimetaphyseal dysplasia (semd)/detection of alleles in humans; gene/protein therapy; fusion proteins; hiv tat genes/proteins
11/16/2004US6818427 MEKK1 molecules and uses thereof
11/16/2004US6818426 (R)-2,3-butanediol dehydrogenase
11/16/2004US6818424 Generation of preferential terpenes; obtain genetically engineered cell, incubate with preferential substrates, recover terpenes
11/16/2004US6818421 DNA sequences coding for enzymes capable of facilitating the synthesis of linear α-1,4 glucans in plants, fungi and microorganisms
11/16/2004US6818419 IRAK-4: compositions and methods of use
11/16/2004US6818414 Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same
11/16/2004US6818217 Immunoreactive peptides
11/16/2004US6818212 Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
11/16/2004CA2136618C Expression of genes in transgenic plants
11/11/2004WO2004097530A1 Structure and method for producing structure, toner containing structure, image forming method and device using toner
11/11/2004WO2004097419A1 Membrane strip biosensor system for point-of-care testing
11/11/2004WO2004097417A1 Structured construct and producing method therefor
11/11/2004WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004WO2004097049A1 Oligoribonucleotides and ribonucleases for cleaving rna
11/11/2004WO2004097047A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia